Folbp1 promotes embryonic myocardial cell proliferation and apoptosis through the WNT signal transduction pathway

International Journal of Molecular Medicine

Volumn 23, Issue 3, 2009, Pages 321-330

  Han, Shu Ping ^a   Pan, Ya ^a   Peng, Yu Zhu ^a   Gu, Xiao Qi ^a   Chen, Rong Hua ^a   Guo, Xi Rong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Folate deficiency; Folate binding protein one; Heart development; Offspring; Wnt signal transduction pathway

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA CATENIN; DNA; FOLATE BINDING PROTEIN; FOLATE BINDING PROTEIN 1; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; TROPONIN I; UNCLASSIFIED DRUG; WNT PROTEIN; BAX PROTEIN, MOUSE; CARRIER PROTEIN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; FOLATE-BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA DETERMINATION; EMBRYO CELL; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC MARKER; HEART DEVELOPMENT; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL EMBRYO; BIOSYNTHESIS; CONGENITAL HEART MALFORMATION; FOLIC ACID DEFICIENCY; GENETICS; HEART MUSCLE; METABOLISM; TUMOR CELL LINE;

ANIMALS; ANTIGENS, DIFFERENTIATION; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; BCL-2-ASSOCIATED X PROTEIN; BETA CATENIN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EMBRYO, MAMMALIAN; FOLIC ACID DEFICIENCY; GENE SILENCING; GLYCOGEN SYNTHASE KINASE 3; HEART DEFECTS, CONGENITAL; MICE; MYOCARDIUM; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TROPONIN I; WNT PROTEINS;

EID: 64249159802     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000134     Document Type: Article

References (22)

1. Gittenberger-de Groot AC, Bartelings MM, Deruiter MC and Poelmann RE: Basics of cardiac development for the understanding of congenital heart malformations. Pediatr Res 57: 169-176, 2005.
2. Scott JM: Reduced folate status is common and increases disease risk. It can be corrected by daily ingestion of supplements or fortification. Novartis Found Symp 282: 105-117, 2007.
3. McDonald SD, Ferguson S, Tam L, Lougheed J and Walker MC: The prevention of congenital anomalies with periconceptional folic acid supplementation. J Obstet Gynaecol Can 25: 115-121, 2003.
4. Botto LD, Mulinare J and Erickson JD: Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet 121: A95-A101, 2003.
5. Piedrahita JA, Oetama B, Bennett GD, et al: Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23: 228-232, 1999.
6. Tang LS, Santillano DR, Wlodarczyk BJ, Miranda RC and Finnell RH: Role of Folbp1 in the regional regulation of apoptosis and cell proliferation in the developing neural tube and craniofacies. Am J Med Genet C Semin Med Genet 135: C48-C58, 2005.
7. da Costa M, Sequeira JM, Rothenberg SP and Weedon J: Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res A Clin Mol Teratol 67: 837-847, 2003.
8. Zhu H, Wlodarczyk BJ, Scott M, et al: Cardiovascular abnormalities in Folr1 knockout mice and folate rescue. Birth Defects Res A Clin Mol Teratol 79: 257-268, 2007.
9. Spiegelstein O, Mitchell LE, Merriweather MY, et al: Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn 231: 221-231, 2004.
10. Nakamura T, Sano M, Songyang Z and Schneider MD: A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci USA 100: 5834-5839, 2003.
11. Moon RT, Bowerman B, Boutros M and Perrimon N: The promise and perils of Wnt signaling through beta-catenin. Science 296: 1644-1646, 2002.
12. van der Heyden MA and Defize LH: Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 58: 292-302, 2003.
13. Chomczynski P and Sacchi N: The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1: 581-585, 2006.
14. Olivera A, Kohama T, Edsall L, et al: Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 147: 545-558, 1999.
15. McBurney MW, Jones-Villeneuve EM, Edwards MK and Anderson PJ: Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299: 165-167, 1982.
16. Fisher SA, Langille BL and Srivastava D: Apoptosis during cardiovascular development. Circ Res 87: 856-864, 2000.
17. Oh H and Schneider MD: The emerging role of telomerase in cardiac muscle cell growth and survival. J Mol Cell Cardiol 34: 717-724, 2002.
18. Li D and Rozen R: Maternal folate deficiency affects proliferation, but not apoptosis, in embryonic mouse heart. J Nutr 136: 1774-1778, 2006.
19. Chen JZ, Zhu JH, Wang XX, et al: Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 36: 233-239, 2004.
20. Buemi M, Marino D, Di Pasquale G, et al: Effects of homocysteine on proliferation, necrosis, and apoptosis of vascular smooth muscle cells in culture and influence of folic acid. Thromb Res 104: 207-213, 2001.
21. Li D, Pickell L, Liu Y, Wu Q, Cohn JS and Rozen R: Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am J Clin Nutr 82: 188-195, 2005.
22. Kwon C, Arnold J, Hsiao EC, Taketo MM, Conklin BR and Srivastava D: Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc Natl Acad Sci USA 104: 10894-10899, 2007.